Apollo Endosurgery Inc (APEN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Apollo Endosurgery Inc (APEN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7363
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company’s product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System and OverStitch endoscopic suturing system; and Lap-Band system for laparoscopic bariatric surgeries. These surgical and non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endo’s products are used by bariatric surgeons, general surgeons and gastroenterologists. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endo is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc (APEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apollo Endosurgery Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 10
Venture Financing 12
Apollo Endosurgery Secures USD50 Million from Athyrium Opportunities Fund 12
Apollo Endosurgery Raises US$60.7 Million In Series C Financing 13
Apollo Endosurgery Raises US$47.6 Million In New Round Of Financing 14
Partnerships 15
Lpath Enters Into Licensing Agreement With Provista Diagnostics For Cancer Diagnostics 15
Apollo Endosurgery Enters into Distribution Agreement with Slater Endoscopy 16
Merger 17
Lpath and Apollo Endosurgery Merges 17
Equity Offering 18
Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 18
Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 20
Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 21
Apollo Endosurgery Inc – Key Competitors 23
Apollo Endosurgery Inc – Key Employees 24
Apollo Endosurgery Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 08, 2018: Apollo Endosurgery reports second quarter 2018 results 26
May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results 27
Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results 28
Oct 26, 2017: Apollo Endosurgery Reports Third Quarter 2017 Results 30
Aug 01, 2017: Apollo Endosurgery Reports Second Quarter 2017 Results 32
Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017 34
May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results 35
Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results 36
Corporate Communications 38
May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors 38
Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Apollo Endosurgery Inc, Medical Equipment, Key Facts, 2017 2
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Deals By Market, 2012 to YTD 2018 8
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 10
Apollo Endosurgery Secures USD50 Million from Athyrium Opportunities Fund 12
Apollo Endosurgery Raises US$60.7 Million In Series C Financing 13
Apollo Endosurgery Raises US$47.6 Million In New Round Of Financing 14
Lpath Enters Into Licensing Agreement With Provista Diagnostics For Cancer Diagnostics 15
Apollo Endosurgery Enters into Distribution Agreement with Slater Endoscopy 16
Lpath and Apollo Endosurgery Merges 17
Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 18
Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 20
Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 21
Apollo Endosurgery Inc, Key Competitors 23
Apollo Endosurgery Inc, Key Employees 24
Apollo Endosurgery Inc, Other Locations 25
Apollo Endosurgery Inc, Subsidiaries 25

List of Figures
Apollo Endosurgery Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Apollo Endosurgery Inc (APEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Abreos Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …
  • Avista Corp (AVA):企業の財務・戦略的SWOT分析
    Avista Corp (AVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • QT Holdings Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary QT Holdings Corp, d.b.a Quad Technologies, a subsidiary of Bio Techne Corp, is a life sciences company that strives to develop bioprocessing reagents for cell-based therapeutics. The company offers QuickGel, a biocompatible dissolvable polymer technology, for cell separation and activation. …
  • HubSpot, Inc.:企業のM&A・事業提携・投資動向
    HubSpot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HubSpot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Prezzo Ltd:企業の戦略・SWOT・財務情報
    Prezzo Ltd - Strategy, SWOT and Corporate Finance Report Summary Prezzo Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • International Datacasting Corporation:企業の戦略的SWOT分析
    International Datacasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Aphios Corp-製薬・医療分野:企業M&A・提携分析
    Summary Aphios Corp (Aphios) is a biotechnology company that develops nanotechnology drug delivery platforms. The company provides technology platforms and enhanced therapeutics for the treatment of infectious diseases, cancers and central nervous system disorders. Its therapeutic products include Z …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Acuity Brands Inc (AYI)-エネルギー分野:企業M&A・提携分析
    Summary Acuity Brands, Inc. (Acuity Brands) provides lighting and building management solutions and services. The company offers lighting solutions including devices such as luminaires, lighting controls, lighting components, power supplies, prismatic skylights, and integrated lighting systems. It a …
  • AgaMatrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary AgaMatrix Inc (AgaMatrix) is a medical device company that offers biosensors and blood glucose monitors. The company designs, develops and manufactures diabetes products for pharmaceutical companies. Its products comprise Jazz Wireless 2, blood glucose monitors, Connected Health and AgaMatri …
  • Hess Corp (HES):企業の財務・戦略的SWOT分析
    Hess Corp (HES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PacifiCorp:発電所・企業SWOT分析
    PacifiCorp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Probi AB (PROB):製薬・医療:M&Aディール及び事業提携情報
    Summary Probi AB (Probi) is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and immune system. It distributes its products to l …
  • Dot Foods, Inc.:企業の戦略・SWOT・財務情報
    Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Wawa Inc:企業の戦略・SWOT・財務情報
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • CompuGroup Medical Deutschland AG (COP):医療機器:M&Aディール及び事業提携情報
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company provides products such as communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety and patient marketin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆